Telehealth demand starts to soften

As healthcare offices closed during the COVID-19 pandemic, telehealth surged. Now that states are reopening, the tide is starting to ebb, according to a recent report from Trilliant.

During COVID-19, roughly 38 million Americans generated 96 million telehealth visits, according to the report, “Trends Shaping the Post-Pandemic Health Economy.” Visit counts soared from fewer than 2 million at the end of 2019 to a peak of more than 12 million by April 2020. By January 2021, when the U.S. began rolling out its vaccine program, telehealth sessions dipped below 10 million again. 

As demand wanes, telehealth service providers are projecting the service will last as a membership service.

“Telehealth services are increasingly being commoditized as a ‘membership’ good that will be adopted by a small segment of Americans,” the report reads.

Teladoc reported that its U.S. paid membership will land in the range of 52 million to 54 million members and fee-only access will be available to 22 million to 23 million individuals, including 2 million to 3 million individuals on a temporary basis, according to its 2021 fourth quarter and year-end earnings results. For fiscal year 2021, the company expects to conduct between 12 million and 13 million telehealth visits.

Some states with tight COVID-19 restrictions reported the highest growth rates in telehealth during the pandemic, including California (1860% growth rate during the pandemic peak in 2020), Massachusetts (1694%), Oregon (1549%), Hawaii (1531%) and Vermont (1512%). Of the top 10 markets with the biggest telehealth demand, six were in California, according to the report.

Even states that saw relatively lower growth rates had triple-digit spikes in telehealth demand. North Dakota had the lowest growth rate during that time218%followed by Wyoming (279%), Mississippi (293%), Iowa (367%) and Arizona (380%). Of the top 10 markets for lowest demand, six were located within Arizona.

With California and other states finally reopening and loosening pandemic restrictions and lockdown measures, the telehealth demand in those areas is finally letting up as well. 

“California experienced both the highest absolute and percentage increase in telehealth utilization during the peak pandemic period,” the report reads.

While many Americans put routine care and elective procedures on hold during COVID-19, one of the biggest demands for telehealth was behavioral health. Forced with lockdown measures and dizzying upsets to everyday life virtually overnight, the pandemic also had a big impact on the mental health of many Americans. As much as 35% of telehealth visits were categorized as mental diseases and disorders. That’s compared to just the 8% proportion for each of the next four most popular categories: Endocrine, Nutritional and Metabolic System; Circulatory System; Musculoskeletal System and Connective Tissue; and Digestive, Kidney and Urinary Tract System.

Additionally, women between 30 and 39 were the top users of telehealth across all periods of the pandemic. Further, the vast majority of telehealth visits for anxiety were commercially insured women. 

 

Related Telehealth Content:

Patient demand for telemedicine remains strong

Telehealth claims surged in 2020

AMA pushes for equity in telehealth

Walmart acquires telehealth provider MeMD

Google takes $100M plunge into telehealth

More than 200 advocates call on governors to retain telehealth flexibilities

HHS awards $55 million to expand virtual healthcare access

Telehealth visits have declined since the onset of COVID-19

Find more telemedicine stories

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup